Park Place Capital Corp

Position in PFE — Pfizer Inc

CIK 1965810 Homewood, AL

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$741,471

+$123,683 QoQ

Shares Held

30,792

+40.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#1,502

of 2,821 holders

Holding Since

Dec 2022

15 quarters on record

Healthcare · as of Jun 30, 2026

Park Place Capital Corp holds $11,539,581 across 14 Drug Manufacturers - General names. PFE ranks #5 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	14,307	$3,600,212
2	BMY	Bristol Myers Squibb Co	61,611	$3,550,025
3	LLY	ELI LILLY & Co	806	$966,740
4	MRK	Merck & Co., Inc.	6,461	$830,237
5	PFE	Pfizer Inc This page	30,792	$741,471
6	SNY	Sanofi	13,474	$574,800
7	JNJ	Johnson & Johnson	2,250	$571,432
8	AMGN	Amgen Inc	1,208	$437,440

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$741,471	30,792	+40.0%	Shares	Sole	2026-08-14
2026-03-31	$617,788	22,001	-17.6%	Shares	Sole	2026-04-09
2025-12-31	$665,153	26,713	-58.5%	Shares	Sole	2026-01-09
2025-09-30	$1,642,084	64,446	+13.7%	Shares	Sole	2025-10-22
2025-06-30	$1,373,995	56,683	+329.3%	Shares	Sole	2025-07-17
2025-03-31	$334,589	13,204	+74.0%	Shares	Sole	2025-04-24
2024-12-31	$201,309	7,588	-36.9%	Shares	Sole	2025-01-17
2024-09-30	$347,800	12,018	-15.5%	Shares	Sole	2024-10-08
2024-06-30	$397,847	14,219	-23.4%	Shares	Sole	2024-07-02
2024-03-31	$515,317	18,570	+4.2%	Shares	Sole	2024-04-18
2023-12-31	$512,865	17,814	-15.1%	Shares	Sole	2024-01-24
2023-09-30	$696,006	20,983	-2.0%	Shares	Sole	2023-10-17
2023-06-30	$785,245	21,408	+3.3%	Shares	Sole	2023-08-04
2023-03-31	$845,172	20,715	+20.4%	Shares	Sole	2023-05-02
2022-12-31	$881,891	17,211	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.